Painkiller dose during surgery may predict chronic pain months later

NCT ID NCT06374849

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether the dose of sufentanil, a strong painkiller given during non-major abdominal surgery, is linked to chronic pain 3 months after the operation. Researchers will interview 855 patients by phone to check for pain and its severity. The goal is to identify a risk factor that anesthesiologists can adjust to potentially lower the chance of long-term pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
sufentanil
What this could lead to
If successful, this could help anesthesiologists choose safer doses of sufentanil to reduce the chance of long-term pain after abdominal surgery.
What could go wrong
This is an observational analysis of existing data, not a controlled experiment. It may only show a link, not cause, and results may not apply to other surgeries or drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens-Picardie

    Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.